Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel B Ho

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Nature Communications|December 14, 2017
Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal EnterococcusCristina Llorente, Peter Jepsen, Tatsuo Inamine, et al.
Hepatology (Baltimore, Md.)|June 23, 2019
Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic HepatitisSonja Lang, Yi Duan, Jinyuan Liu, et al.
The American Journal of Gastroenterology|August 10, 2005
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infectionEdmund J Bini, Norbert Bräu, Sue Currie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2015
Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiencyBrigid S Boland, Christella E Widjaja, Asoka Banno, et al.
Hepatology (Baltimore, Md.)|July 13, 2020
Intestinal Virome in Patients With Alcoholic HepatitisLu Jiang, Sonja Lang, Yi Duan, et al.
The Journal of Clinical Investigation|May 23, 2017
Intestinal fungi contribute to development of alcoholic liver diseaseAn-Ming Yang, Tatsuo Inamine, Katrin Hochrath, et al.
Journal of Hepatology|April 15, 2018
Dysregulation of serum bile acids and FGF19 in alcoholic hepatitisKatharina Brandl, Phillipp Hartmann, Lily J Jih, et al.
The American Journal of Gastroenterology|December 7, 2016
Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled TrialChristopher C Thompson, Barham K Abu Dayyeh, Robert Kushner, et al.
Nature|November 15, 2019
Bacteriophage targeting of gut bacterium attenuates alcoholic liver diseaseYi Duan, Cristina Llorente, Sonja Lang, et al.
JAMA Network Open|July 11, 2023
Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening TrialDouglas J Robertson, Jason A Dominitz, Alexander Beed, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Nature Communications|December 14, 2017
Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal EnterococcusCristina Llorente, Peter Jepsen, Tatsuo Inamine, et al.
Hepatology (Baltimore, Md.)|June 23, 2019
Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic HepatitisSonja Lang, Yi Duan, Jinyuan Liu, et al.
The American Journal of Gastroenterology|August 10, 2005
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infectionEdmund J Bini, Norbert Bräu, Sue Currie, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2015
Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiencyBrigid S Boland, Christella E Widjaja, Asoka Banno, et al.
Hepatology (Baltimore, Md.)|July 13, 2020
Intestinal Virome in Patients With Alcoholic HepatitisLu Jiang, Sonja Lang, Yi Duan, et al.
The Journal of Clinical Investigation|May 23, 2017
Intestinal fungi contribute to development of alcoholic liver diseaseAn-Ming Yang, Tatsuo Inamine, Katrin Hochrath, et al.
Journal of Hepatology|April 15, 2018
Dysregulation of serum bile acids and FGF19 in alcoholic hepatitisKatharina Brandl, Phillipp Hartmann, Lily J Jih, et al.
The American Journal of Gastroenterology|December 7, 2016
Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled TrialChristopher C Thompson, Barham K Abu Dayyeh, Robert Kushner, et al.
Nature|November 15, 2019
Bacteriophage targeting of gut bacterium attenuates alcoholic liver diseaseYi Duan, Cristina Llorente, Sonja Lang, et al.
JAMA Network Open|July 11, 2023
Baseline Features and Reasons for Nonparticipation in the Colonoscopy Versus Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM) Study, a Colorectal Cancer Screening TrialDouglas J Robertson, Jason A Dominitz, Alexander Beed, et al.
Pageof 14